These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11146392)

  • 1. Suppressive effect of topically applied CX-659S, a novel diaminouracil derivative, on the contact hypersensitivity reaction in various animal models.
    Goto Y; Inoue Y; Tsuchiya M; Isobe M; Ueno T; Uchi H; Furue M; Hayashi H
    Int Arch Allergy Immunol; 2000 Dec; 123(4):341-8. PubMed ID: 11146392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective and curative effects of topically applied CX-659S, a novel diaminouracil derivative, on chronic picryl chloride-induced contact hypersensitivity responses.
    Inoue Y; Isobe M; Shiohara T; Goto Y; Hayashi H
    Br J Dermatol; 2002 Oct; 147(4):675-82. PubMed ID: 12366412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effect of topical CX-659S, a novel diaminouracil derivative, with topical corticosteroid on the three types of allergic responses in mice or guinea pigs.
    Inoue Y; Isobe M; Hayashi H
    J Pharmacol Sci; 2003 Jan; 91(1):71-8. PubMed ID: 12686733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses.
    Inoue Y; Isobe M; Shiohara T; Hayashi H
    Int Arch Allergy Immunol; 2003 Jun; 131(2):143-52. PubMed ID: 12811023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CX-659S: a novel diaminouracil derivative that has antioxidative and acute anti-inflammatory activities.
    Goto Y; Watanabe N; Kogawa N; Tsuchiya M; Takahashi O; Uchi H; Furue M; Hayashi H
    Eur J Pharmacol; 2002 Mar; 438(3):189-96. PubMed ID: 11909611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX-659S, a diaminouracil derivative, indirectly inhibits the function of Langerhans cells by blocking the MEK1/2-Erk1/2 pathway in keratinocytes.
    Uchi H; Koga T; Urabe K; Moroi Y; Furue M
    J Invest Dermatol; 2003 Jun; 120(6):983-9. PubMed ID: 12787125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and activity of a metabolite of (S)-6-amino-5-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)-3-methyl-1-phenyl-2,4-(1H,3H)-pyrimidinedione (CX-659S).
    Isobe Y; Tobe M; Takahashi O; Goto Y; Inoue Y; Obara F; Tsuchiya M; Hayashi H
    Chem Pharm Bull (Tokyo); 2002 Oct; 50(10):1418-20. PubMed ID: 12372880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of CX-659S and its related compounds for their inhibitory effects on the delayed-type hypersensitivity reaction.
    Tobe M; Isobe Y; Goto Y; Obara F; Tsuchiya M; Matsui J; Hirota K; Hayashi H
    Bioorg Med Chem; 2000 Aug; 8(8):2037-47. PubMed ID: 11003148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical application of Kochia scoparia inhibits the development of contact dermatitis in mice.
    Choi YY; Kim MH; Lee JY; Hong J; Kim SH; Yang WM
    J Ethnopharmacol; 2014 Jun; 154(2):380-5. PubMed ID: 24751363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical application of cyclosporine on guinea pig allergic contact dermatitis.
    Nakagawa S; Oka D; Jinno Y; Takei Y; Bang D; Ueki H
    Arch Dermatol; 1988 Jun; 124(6):907-10. PubMed ID: 3270996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases.
    Tobe M; Tsuboi K; Hasegawa F; Fujiwara N; Inoue Y; Isobe M; Isobe Y
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1292-5. PubMed ID: 26786694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation of contact dermatitis.
    Lauerma AI
    Curr Probl Dermatol; 1995; 22():51-3. PubMed ID: 7587333
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, in NC/Nga mice.
    Kang JS; Yoon WK; Youm JK; Jeong SK; Park BD; Han MH; Lee H; Moon EY; Han SB; Lee CW; Lee K; Park SK; Yang KH; Kim HM
    Exp Dermatol; 2008 Nov; 17(11):958-64. PubMed ID: 18721197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses.
    Homey B; Assmann T; Vohr HW; Ulrich P; Lauerma AI; Ruzicka T; Lehmann P; Schuppe HC
    J Immunol; 1998 Jun; 160(11):5331-40. PubMed ID: 9605132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models.
    Tolstrup M; Johansen C; Toft L; Pedersen FS; Funding A; Bahrami S; Iversen L; Østergaard L; Duch M
    BMC Immunol; 2013 Nov; 14():51. PubMed ID: 24245569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An isoflavone extract from soybean cake suppresses 2,4-dinitrochlorobenzene-induced contact dermatitis.
    Chu T; Wu NL; Hsiao CY; Li HJ; Lin TY; Ku CH; Hung CF
    J Ethnopharmacol; 2020 Dec; 263():113037. PubMed ID: 32485302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical application of Scutellaria baicalensis suppresses 2,4-dinitrochlorobenzene-induced contact dermatitis.
    Kim TW; Choi JM; Kim MS; Son HY; Lim JH
    Nat Prod Res; 2016; 30(6):705-9. PubMed ID: 25942587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and activity relationships of novel uracil derivatives as topical anti-inflammatory agents.
    Isobe Y; Tobe M; Inoue Y; Isobe M; Tsuchiya M; Hayashi H
    Bioorg Med Chem; 2003 Nov; 11(23):4933-40. PubMed ID: 14604654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice.
    Tamura T; Matsubara M; Takada C; Hasegawa K; Suzuki K; Ohmori K; Karasawa A
    Br J Dermatol; 2004 Dec; 151(6):1133-42. PubMed ID: 15606507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis.
    Hwang JS; Kim JE; Kim HT; Yu YB; Im SH
    J Ethnopharmacol; 2013 Jan; 145(2):536-46. PubMed ID: 23211659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.